Allergan's sales of eye care pharmaceuticals rose in the second...

Allergan's sales of eye care pharmaceuticals rose in the second quarter by 13.8 percent to $657.6 million as compared to the same period one year ago, with a rise of 10.1 percent in local currencies. The company's total net product sales rose 13.7 percent to $1,400.4 million, up by 9.6 ...

You need to register to continue reading this article

Already subscribe to Eyewear intelligence? Sign in here

Register to continue reading

By registering today you will have access to:

  • 3 industry news articles per month

For full access and to receive in-depth news, analysis and more, become a member today

For more content and resources become a member? View our membership packages.